MSPR vs ATAI vs CMPS vs CLCO vs MNMD

For growth investors, MSP Recovery, Inc.

(MSPR) is the stronger pick with 136. 8% revenue growth year-over-year, versus -10. 8% for Cool Company Ltd. (CLCO). Cool Company Ltd. (CLCO) offers the better valuation at 5. 3x trailing P/E (12. 1x forward), making it the more compelling value choice. Analysts rate Atai Beckley N. V (ATAI) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Cool Company Ltd.

(CLCO) delivered a total return of +1. 9%, compared to -99. 8% for MSP Recovery, Inc. (MSPR). Over 10 years, the gap is even starker: MNMD returned +512. 1% versus MSPR's -99. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Cool Company Ltd.

(CLCO) is the lower-risk stock at 0. 16β versus Mind Medicine (MindMed) Inc. 's 1. 63β — meaning MNMD is approximately 925% more volatile than CLCO relative to the S&P 500. On balance sheet safety, Atai Beckley N. V (ATAI) carries a lower debt/equity ratio of 21% versus 172% for Cool Company Ltd. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), MSP Recovery, Inc.

(MSPR) is pulling ahead at 136. 8% versus -10. 8% for Cool Company Ltd. (CLCO). On earnings-per-share growth, the picture is similar: COMPASS Pathways plc grew EPS -33. 9% year-over-year, compared to -1273. 3% for Mind Medicine (MindMed) Inc.. Over a 3-year CAGR, CLCO leads at 25. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Cool Company Ltd.

(CLCO) is the more profitable company, earning 30. 4% net margin versus -484. 6% for Atai Beckley N. V — meaning it keeps 30. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CLCO leads at 50. 5% versus -333. 4% for ATAI. At the gross margin level — before operating expenses — ATAI leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for ATAI: 197.

8% to $12. 00.

In this comparison, CLCO (14.

2% yield) pays a dividend. MSPR, ATAI, CMPS, MNMD do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Cool Company Ltd.

(CLCO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 16), 14. 2% yield). Both have compounded well over 10 years (CLCO: +1. 9%, ATAI: -47. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (MSPR (Healthcare) and ATAI (Healthcare) and CMPS (Healthcare) and CLCO (Industrials) and MNMD (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: MSPR is a small-cap high-growth stock; ATAI is a small-cap quality compounder stock; CMPS is a small-cap quality compounder stock; CLCO is a small-cap deep-value stock; MNMD is a small-cap quality compounder stock. CLCO pays a dividend while MSPR, ATAI, CMPS, MNMD do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.